These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36260317)

  • 1. Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing.
    Shi K; Li Y; Yang L; Zhang Z; Guo D; Zhang J; Lu Y
    FASEB J; 2022 Nov; 36(11):e22620. PubMed ID: 36260317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing reveals the MIF-ACKR3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma.
    Liang J; Lei K; Liang R; Huang J; Tan B; Lin H; Wang M
    Cell Signal; 2024 May; 117():111093. PubMed ID: 38336189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.
    Dinh HQ; Pan F; Wang G; Huang QF; Olingy CE; Wu ZY; Wang SH; Xu X; Xu XE; He JZ; Yang Q; Orsulic S; Haro M; Li LY; Huang GW; Breunig JJ; Koeffler HP; Hedrick CC; Xu LY; Lin DC; Li EM
    Nat Commun; 2021 Dec; 12(1):7335. PubMed ID: 34921160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
    He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
    J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
    Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
    Chen Z; Zhao M; Liang J; Hu Z; Huang Y; Li M; Pang Y; Lu T; Sui Q; Zhan C; Lin M; Guo W; Wang Q; Tan L
    EBioMedicine; 2021 Jul; 69():103459. PubMed ID: 34192657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.
    Ji G; Yang Q; Wang S; Yan X; Ou Q; Gong L; Zhao J; Zhou Y; Tian F; Lei J; Mu X; Wang J; Wang T; Wang X; Sun J; Zhang J; Jia C; Jiang T; Zhao MG; Lu Q
    Genome Med; 2024 Apr; 16(1):49. PubMed ID: 38566201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
    Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
    J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Liu M; Li F; Liu B; Jian Y; Zhang D; Zhou H; Wang Y; Xu Z
    BMC Med Genomics; 2021 Mar; 14(1):75. PubMed ID: 33691689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Li W; Xu T; Jin H; Li M; Jia Q
    Pathol Res Pract; 2024 Jan; 253():155002. PubMed ID: 38056131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer.
    Wei J; Wu X; Wang S; Liu S; Gao X
    Front Endocrinol (Lausanne); 2023; 14():1138457. PubMed ID: 37091857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.
    Zhang X; Peng L; Luo Y; Zhang S; Pu Y; Chen Y; Guo W; Yao J; Shao M; Fan W; Cui Q; Xi Y; Sun Y; Niu X; Zhao X; Chen L; Wang Y; Liu Y; Yang X; Wang C; Zhong C; Tan W; Wang J; Wu C; Lin D
    Nat Commun; 2021 Sep; 12(1):5291. PubMed ID: 34489433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
    Ko KP; Huang Y; Zhang S; Zou G; Kim B; Zhang J; Jun S; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Park JI
    Gastroenterology; 2023 Sep; 165(3):613-628.e20. PubMed ID: 37257519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma.
    Guo W; Zhou B; Yang Z; Liu X; Huai Q; Guo L; Xue X; Tan F; Li Y; Xue Q; Gao S; He J
    EBioMedicine; 2022 Oct; 84():104281. PubMed ID: 36162205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
    Zheng Y; Chen Z; Han Y; Han L; Zou X; Zhou B; Hu R; Hao J; Bai S; Xiao H; Li WV; Bueker A; Ma Y; Xie G; Yang J; Chen S; Li H; Cao J; Shen L
    Nat Commun; 2020 Dec; 11(1):6268. PubMed ID: 33293583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma.
    Li Y; Xu F; Chen F; Chen Y; Ge D; Zhang S; Lu C
    EBioMedicine; 2021 Aug; 70():103510. PubMed ID: 34365093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
    Li C; Song W; Zhang J; Luo Y
    Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.